James C. Lanter

768 total citations
34 papers, 584 citations indexed

About

James C. Lanter is a scholar working on Organic Chemistry, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, James C. Lanter has authored 34 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 11 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Molecular Biology. Recurrent topics in James C. Lanter's work include Hormonal and reproductive studies (8 papers), Estrogen and related hormone effects (7 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). James C. Lanter is often cited by papers focused on Hormonal and reproductive studies (8 papers), Estrogen and related hormone effects (7 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). James C. Lanter collaborates with scholars based in United States, Netherlands and Belgium. James C. Lanter's co-authors include Zhihua Sui, Xuqing Zhang, Leo A. Paquette, George F. Allan, Scott G. Lundeen, Jeffrey N. Johnston, Chaozhong Cai, Hongfeng Chen, Fu‐An Kang and William V. Murray and has published in prestigious journals such as Gastroenterology, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

James C. Lanter

34 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James C. Lanter United States 18 392 180 93 50 49 34 584
Robert I. Higuchi United States 11 218 0.6× 148 0.8× 143 1.5× 30 0.6× 164 3.3× 18 446
Candido Gude United States 12 487 1.2× 196 1.1× 29 0.3× 37 0.7× 82 1.7× 24 670
Olivia Linton United States 13 211 0.5× 103 0.6× 136 1.5× 23 0.5× 102 2.1× 17 386
Mihály Szécsi Hungary 18 337 0.9× 322 1.8× 98 1.1× 12 0.2× 269 5.5× 46 664
Iain A. S. Walters United Kingdom 15 432 1.1× 335 1.9× 37 0.4× 55 1.1× 29 0.6× 20 705
Christopher A. Teleha United States 13 393 1.0× 234 1.3× 17 0.2× 56 1.1× 20 0.4× 32 668
Feroze Ujjainwalla United States 16 523 1.3× 299 1.7× 18 0.2× 32 0.6× 67 1.4× 28 952
A. Mayweg Switzerland 13 308 0.8× 189 1.1× 33 0.4× 28 0.6× 9 0.2× 19 576
Christiane Scherer Germany 9 229 0.6× 162 0.9× 120 1.3× 19 0.4× 87 1.8× 11 471
Lauren G. Monovich United States 10 195 0.5× 246 1.4× 28 0.3× 21 0.4× 15 0.3× 11 462

Countries citing papers authored by James C. Lanter

Since Specialization
Citations

This map shows the geographic impact of James C. Lanter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Lanter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Lanter more than expected).

Fields of papers citing papers by James C. Lanter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Lanter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Lanter. The network helps show where James C. Lanter may publish in the future.

Co-authorship network of co-authors of James C. Lanter

This figure shows the co-authorship network connecting the top 25 collaborators of James C. Lanter. A scholar is included among the top collaborators of James C. Lanter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Lanter. James C. Lanter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Xiaowen, Christopher J. Holler, Angelo Pugliese, et al.. (2023). Discovery and characterization of novel TRPML1 agonists. Bioorganic & Medicinal Chemistry Letters. 98. 129595–129595. 3 indexed citations
2.
Hurst, Raymond S, Jean‐François Blain, Christopher J. Holler, et al.. (2023). ARKD‐104, A Potential Treatment of Frontotemporal Dementia and Other Neurodegenerative Disorders. Alzheimer s & Dementia. 19(S21). 1 indexed citations
3.
Peng, Xiaowen, James C. Lanter, Wim Zonneveld, et al.. (2022). Discovery of oxazoline enhancers of cellular progranulin release. Bioorganic & Medicinal Chemistry Letters. 80. 129048–129048. 2 indexed citations
4.
Lanter, James C., et al.. (2021). Discovery of quinuclidine modulators of cellular progranulin. Bioorganic & Medicinal Chemistry Letters. 47. 128209–128209. 3 indexed citations
5.
Zhang, Xuqing, Bin Zhu, Weimei Sun, et al.. (2021). Discovery of a novel series of guanidinebenzoates as gut-restricted enteropeptidase and trypsin dual inhibitors for the treatment of metabolic syndrome. Bioorganic & Medicinal Chemistry Letters. 40. 127939–127939. 2 indexed citations
6.
Sun, Weimei, Xuqing Zhang, Maxwell D. Cummings, et al.. (2020). Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits. Journal of Pharmacology and Experimental Therapeutics. 375(3). 510–521. 17 indexed citations
7.
Huang, Hui, Sanath K. Meegalla, James C. Lanter, et al.. (2018). Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination. ACS Medicinal Chemistry Letters. 10(1). 16–21. 18 indexed citations
8.
Subasinghe, Nalin L., James C. Lanter, Evan E. Opas, et al.. (2012). A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 23(4). 1063–1069. 17 indexed citations
9.
Zhang, Xuqing, James C. Lanter, Chaozhong Cai, et al.. (2011). Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(18). 5577–5582. 18 indexed citations
10.
Lanter, James C., Xuqing Zhang, & Zhihua Sui. (2011). Medicinal Chemistry Inspired Fragment-Based Drug Discovery. Methods in enzymology on CD-ROM/Methods in enzymology. 493. 421–445. 4 indexed citations
11.
Kang, Fu‐An, James C. Lanter, Chaozhong Cai, Zhihua Sui, & William V. Murray. (2010). Direct dehydrative cross-coupling of tautomerizable heterocycles with alkynes via Pd/Cu-catalyzed phosphonium coupling. Chemical Communications. 46(8). 1347–1347. 56 indexed citations
12.
Zhang, Xuqing, James C. Lanter, & Zhihua Sui. (2009). Recent advances in the development of selective androgen receptor modulators. Expert Opinion on Therapeutic Patents. 19(9). 1239–1258. 18 indexed citations
13.
Lanter, James C., Xuqing Zhang, Kenneth M. Wells, et al.. (2007). β-Alkylthio indolyl carbinols: Potent nonsteroidal antiandrogens with oral efficacy in a prostate cancer model. Bioorganic & Medicinal Chemistry Letters. 17(9). 2545–2548. 9 indexed citations
14.
Lanter, James C., et al.. (2006). A bioisosteric approach to the discovery of indole carbinol androgen receptor ligands. Bioorganic & Medicinal Chemistry Letters. 16(21). 5646–5649. 16 indexed citations
15.
Lanter, James C., et al.. (2006). Synthesis of potent and tissue-selective androgen receptor modulators (SARMs): 2-(2,2,2)-Trifluoroethyl-benzimidazole scaffold. Bioorganic & Medicinal Chemistry Letters. 17(6). 1784–1787. 28 indexed citations
16.
Lanter, James C., et al.. (2006). 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(4). 955–958. 22 indexed citations
17.
Lanter, James C., Weiqin Jiang, George F. Allan, et al.. (2006). The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening. Bioorganic & Medicinal Chemistry Letters. 17(1). 123–126. 23 indexed citations
18.
Lanter, James C., et al.. (2006). Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives. Bioorganic & Medicinal Chemistry Letters. 17(3). 784–788. 33 indexed citations
19.
Allan, George F., Olivia Linton, Donna Haynes‐Johnson, et al.. (2006). A selective androgen receptor modulator that reduces prostate tumor size and prevents orchidectomy-induced bone loss in rats. The Journal of Steroid Biochemistry and Molecular Biology. 103(1). 76–83. 17 indexed citations
20.
Detert, Heiner, James C. Lanter, & Leo A. Paquette. (1995). Weiss-Cook Condensations Involving Unsaturated and Transannularly Alkylated Cyclododecane-1,2-diones. The Journal of Organic Chemistry. 60(2). 353–356. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert I. Higuchi Breakdown of academic impact, for papers by Candido Gude Breakdown of academic impact, for papers by Olivia Linton Breakdown of academic impact, for papers by Mihály Szécsi Breakdown of academic impact, for papers by Iain A. S. Walters Breakdown of academic impact, for papers by Christopher A. Teleha Breakdown of academic impact, for papers by Feroze Ujjainwalla Breakdown of academic impact, for papers by A. Mayweg Breakdown of academic impact, for papers by Christiane Scherer Breakdown of academic impact, for papers by Lauren G. Monovich
Rankless by CCL
2026